Key result
Fetal myocardial hypertrophy was significantly more severe at term in poorly controlled diabetic pregnancies compared to controls, and predicted neonatal morbidities like hypoglycemia.
Why the study?
Data from India were sparse regarding whether fetal echocardiography among pregnant diabetics could help predict adverse perinatal or neonatal outcomes.
Does fetal echocardiography at term in diabetic pregnancies predict adverse neonatal outcomes?
Comparison
Pregnant diabetics (17 overt, 66 gestational) vs healthy non-diabetic controls
Design
Prospective observational cohort study
Follow-up
From 24 weeks gestation until between 4 and 7 days on neonates
Authors
Loading...
Fetal echo at term may flag neonatal risk in diabetic pregnancies; leaves open whether routine screening improves outcomes.
Cohort (n=185)
No
Does fetal echocardiography at term in diabetic pregnancies predict adverse neonatal outcomes?
Absolute Event Rate: 6.16% vs 4.97%
p-value: p=<0.001
Fetal echocardiography at term in diabetic pregnancies reveals myocardial hypertrophy that correlates with suboptimal glycemic control and predicts adverse neonatal outcomes like hypoglycemia.
Tejaswi et al. (2020) conducted a cohort in Gestational diabetes mellitus (n=185). Maternal diabetes vs. Healthy non-diabetic pregnancies was evaluated on Interventricular septum thickness (IVSD) at >37 weeks gestation (mm) (p=<0.001). Fetal myocardial hypertrophy was significantly more severe at term in poorly controlled diabetic pregnancies compared to controls, and predicted neonatal morbidities like hypoglycemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: